Breaking News
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
February 22, 2019 - Growing number of cancer survivors, fewer providers point to challenge in meeting care needs
February 22, 2019 - Innovative compound offers a new therapeutic approach to treat multiple sclerosis
February 22, 2019 - $1.5 million grant to develop opioid treatment program for jail detainees
February 22, 2019 - FDA’s new proposed rule would update regulatory requirements for sunscreen products in the U.S
February 22, 2019 - Most Hip, Knee Replacements Last Decades, Study Finds
February 22, 2019 - Wellness problems prevalent among ob-gyn residents
February 22, 2019 - In the Spotlight: “The world is your oyster in geriatrics”
February 22, 2019 - Successful testing of multi-organ “human-on-a-chip” could replace animals as test subjects
February 22, 2019 - Analysis of cervical precancer shows decline in two strains of HPV
February 22, 2019 - Sugary stent eases suturing of blood vessels
February 22, 2019 - From surgery to psychiatry: A medical student reevaluates his motivations
February 22, 2019 - Is New App From Feds Your Answer To Navigating Medicare Coverage? Yes And No
February 22, 2019 - New pacemakers powered by heartbeats could reduce need for surgery
February 22, 2019 - The United States records highest drug overdose death rates
February 22, 2019 - Phase 1 data reinforce safety profile of new drug for treating Duchenne muscular dystrophy
February 22, 2019 - Vitamin D supplementation less effective in the presence of obesity, shows study
February 22, 2019 - Novostia raises CHF 6.5 million to advance its aortic, mitral heart valve to clinical trials
February 22, 2019 - CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center
February 22, 2019 - Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53
February 22, 2019 - An institutional effort to reduce the amount of opioids prescribed following lumbar surgery
February 22, 2019 - Family-history-based models perform better than non-family-history based models
February 22, 2019 - Failure to take statins leads to higher mortality rates | News Center
February 22, 2019 - New study explains why some patients report phantom sensations after limb amputation
February 22, 2019 - First motor-controlled heart valves implanted by Mainz University Medical Center
February 22, 2019 - Novel preclinical model mimics persistent interneuron loss seen in preterm infants
February 22, 2019 - Global health burden of glaucoma has increased, study reveals
February 22, 2019 - A holistic approach key to minimize treatment complexity in patients with interstitial lung disease
February 22, 2019 - 1 in 10 middle-aged Chinese adults are at high risk for heart disease, finds study
February 22, 2019 - More than half a million breast cancer patient’s lives saved by improvements in treatment
February 22, 2019 - Study finds no evidence that tougher policies prevent teenage cannabis use
February 22, 2019 - New blood test detects genetic disorders in fetuses
February 22, 2019 - Lower Self-Perception Observed in Children With Amblyopia
February 22, 2019 - Up to 15 percent of children have sleep apnea, yet 90 percent go undiagnosed
February 22, 2019 - Rare pulmonary defect prompts parents’ nationwide search for answers | News Center
February 22, 2019 - Lesbian and bisexual women at greater risk of being overweight, study finds
February 22, 2019 - UQ research may explain why vitamin D is essential for brain health
February 22, 2019 - Heart Attacks Rising Among Younger Women
February 22, 2019 - How your smartphone is affecting your relationship
February 22, 2019 - Orthopaedic surgeon receives prestigious award, $10 million grant | News Center
February 22, 2019 - New sepsis test could save thousands of lives
February 22, 2019 - Cervical cancer could be eradicated by 2100
February 21, 2019 - Sustained smoking cessation can lower risk of seropositive RA
February 21, 2019 - Thousands with chronic UTIs are not receiving the treatment they need
February 21, 2019 - Are teens getting high on social media? The surprising study seeking the pot-Instagram link
February 21, 2019 - Stanford expands biobank services | News Center
February 21, 2019 - Scientists identify link between drinking contexts and early onset intoxication among adolescents
February 21, 2019 - Strong social support may reduce cardiovascular disease risk in postmenopausal women
February 21, 2019 - Rapid expansion of interventions could prevent up to 13 million cases of cervical cancer within 50 years
February 21, 2019 - Motif Bio Receives Complete Response Letter From The FDA
February 21, 2019 - Researchers map previously unknown disease in children
February 21, 2019 - A skeptical look at popular diets: Going gluten-free
February 21, 2019 - Podcast: KHN’s ‘What The Health?’ How Safe Are Your Supplements?
February 21, 2019 - Factors associated with increased risk of developing surgical site infections
February 21, 2019 - Anticipatory signals in eye movements can help measure attentive capacity, learning with greater precision
February 21, 2019 - Study explores daily exposure to indoor air pollutants
February 21, 2019 - Evening exercise does not negatively affect sleep, may also reduce hunger
February 21, 2019 - Artificial intelligence technique can be used to identify alcohol misuse in trauma setting
Tobacco control must be highest priority in national cancer control plan, says report

Tobacco control must be highest priority in national cancer control plan, says report

image_pdfDownload PDFimage_print

The highest priority in a national cancer control plan must be expansion of tobacco control–the intervention with the largest potential health benefits–according to a new American Cancer Society report, the second in a series of articles that together inform priorities for a comprehensive cancer control plan. The report, appearing in CA: A Cancer Journal for Clinicians, says that although some cancer prevention interventions, such as increasing HPV vaccination rates, can be implemented fairly quickly, others, including promoting access to healthier living environments and addressing the social determinants of health, will require concerted and sustained efforts.

The second article in the series focuses on existing evidence about established, modifiable risk factors for cancer, the cancer burden in the United States due to each risk factor, and established primary prevention recommendations and interventions to reduce exposure to each risk factor. The report was led by Susan M. Gapstur, Ph.D., MPH, American Cancer Society Senior Vice President of Behavioral and Epidemiology Research.

The report focuses on several important modifiable risk factors:

Tobacco: More than half of the 26% decline in cancer mortality rates in the U.S. since 1991 is due to reductions in tobacco smoking. Despite this progress, tobacco smoking (active and second-hand smoke) remains the most common cause of cancers diagnosed (19.4%, n=304,880) and cancer death (29.6%, n=173,670). Moreover, the annual direct health care costs of tobacco in the U.S. are estimated to be $170 billion, and tobacco use results in $156 billion in lost productivity. There is considerable evidence that tobacco control can prevent more cancer deaths than any other primary prevention strategy.

The demographic profile of today’s smoker has changed over the last half century.

Today, tobacco use is more prevalent among persons with lower educational attainment; lower income; within vulnerable populations, such as individuals with mental illness or addiction to other substances; within the Lesbian, Gay, Bisexual, Transgender (LGBT) community; and within certain racial or ethnic groups. Enhanced efforts to reach groups that are more likely to smoke are needed to further reduce the prevalence of tobacco use.

Obesity and overweight: In the U.S., approximately, 7.8% of cancer cases in 2014 were attributed to excess body fatness, second only to cigarette smoking. Its contribution was higher among women (10.9% of cases) than among men (4.8% of cases). Among women, 60.3% of uterine cancer and, among men and women combined, more than 30% of gallbladder, liver, and kidney/renal cancers as well as esophageal adenocarcinoma were attributed to excess body fatness. Despite clear evidence that excess body fatness contributes substantially to cancer risk, the full impact of the obesity epidemic on the cancer burden, including the long-term effect of obesity that begins in childhood, is yet to be completely understood.

Alcohol: Alcohol is the third most-important major modifiable contributor to cancer, associated with 6.4% of cancers in women and 4.8% of cancers in men in 2014. However, for some cancers, the attributable fraction exceeds 10%; among men and women combined, an estimated 40.9% of oral cavity/pharynx cancers, 23.2% of larynx cancers, 21.6% of liver cancers, 21% of esophageal cancers, and 12.8% of colorectal cancers were attributed to alcohol consumption. Notably, among women, alcohol intake accounted for 16.4% of all cases, or 39,060 breast cancers in 2014.

Diet: The combination of low calcium, fiber, and fruit and vegetable intake and high red and processed meat intake is estimated to cause 4.2% of cancers among men and women combined. However, there was considerable variation across specific dietary factors and types of cancer. For example, 5.4% of colorectal cancers are associated with high red meat consumption causes, 8.2% with high processed meat consumption, and 10.3% and 4.9% for low dietary fiber and calcium consumption, respectively. Low fruit and vegetable consumption was attributed to 17.6% and 17.4% of oral cavity/pharynx and larynx cancers, respectively. A lack of clear evidence about the role of early life dietary exposures as well as many other dietary hypotheses means the percentage of cancers attributable to diet may continue to rise beyond current estimates once more is known.

Physical inactivity It is estimated that 2.9% of all cancer cases in the U.S. in 2014 were attributable to low physical activity, with the contribution greater among women (4.4%) than among men (1.5%). The cancer with the highest percentage related to low physical activity was uterine cancer (26.7%), followed by colorectal cancer (6.3% among men and women combined). As additional cancer types are determined to be causally associated with low amounts of physical activity, the total number of cancer cases attributed to low physical activity will continue to rise.

In the U.S., an estimated 13.9% of cancers among men and 22.4% among women in 2014 were attributable to the combination of excess body weight, poor diet, physical inactivity, and alcohol consumption. Reversing the obesity epidemic and increasing the prevalence of healthy eating and active living hold considerable potential for reducing cancer incidence and mortality rates. Achieving this potential, write the authors, will require a comprehensive approach, including evidence-based, primary prevention interventions that target communities and individuals.

Sugar-sweetened beverage consumption has been consistently associated with weight gain, overweight, and obesity. Consistent with the effectiveness of raising tobacco taxes on reducing the use of tobacco products, the broad implementation of excise taxes on these products has the potential to reduce consumption of sugar sweetened beverages.

In the U.S., an estimated 4% of human cancers are attributed to infectious agents. For several types of cancer, infectious agents are the dominant known risk factors. The report details six of the eleven pathogens classified as being human carcinogens: H. pylori (the only bacterium), human papillomavirus (HPV), hepatitis B, hepatitis C, Epstein-Barr, and human immunodeficiency virus (HIV).

Recent estimates indicate that approximately 95% of all cutaneous melanoma cases in the U.S. may be attributable to UV radiation exposure from the sun and indoor tanning. More than 9000 men and women die each year from melanoma in the U.S. alone.

The proportion of ionizing radiation the general public is exposed to that comes from medical sources has increased significantly. In the 1980s, exposure from things like diagnostic and therapeutic procedures accounted for 15% of total radiation exposure. By 2006, that proportion had risen to 48%. The large increase has been attributed to significant increases in the number of CT procedures.

Radon exposure caused 13% (21,000) of all lung cancer deaths in the U.S. in 1995, making radon the second leading cause of lung cancer behind smoking. According to a risk assessment by the National Research Council, approximately 3% to 4% of all lung cancer deaths in the U.S. could be prevented by mitigating all homes with radon levels at or above the EPA action level.

“A comprehensive cancer control plan designed to support the implementation of evidence-based interventions, including cancer prevention interventions like those we described has enormous potential to substantially reduce the number of individuals diagnosed with and dying from cancer,” said Dr. Gapstur. “It is the responsibility of government and industry as well as the public health, medical, and scientific communities to work together to invest in and implement a comprehensive cancer control plan at the national level and support and expand ongoing initiatives at the state and local levels. If we fail to do so, we will slow progress in our national efforts to reduce the burden of cancer.”

Source:

http://pressroom.cancer.org/Ch2Blueprint

Tagged with:

About author

Related Articles